As costs go up, how can the industry adapt?

Healthcare costs continue to rise across the industry. According to a study published in the Journal of the American Medical Association, money spent on healthcare in the U.S. is nearly twice as high as 10 high-income countries. Not only does the U.S. have the highest percentage of obese adults but it also has the lowest life expectancy and the highest infant mortality rates compared to 10 high-income counties. What’s driving these costs? According to Harvard researchers, prescription drug prices and administrative costs are the main culprits.

Prescription Drug Prices

Prescription drug costs are high, not only for payers, but also for the patients that need these life-saving drugs. Unfortunately, treatment for some diseases can cost nearly a million dollars as one Wall Street Journal article explores. The administration is looking to put policies in place to cut costs, but what can be done at the health system level to help these efforts?

St. Joseph Hospital, part of Covenant Health, leverages MedeAnalytics to analyze their pharmaceutical spend and identify cost saving opportunities. The health system found that an extremely high percentage of their pharma spend came from specialty drugs. They were able to identify $100,000 in potential savings, just from generic drug substitution in three therapeutic classes where generic equivalents were available. Additionally, pharmaceutical data revealed one patient with a single drug at a special dosage cost $700 for a 30-day supply. Using analytics, the organization confirmed the cost was correct but also found other patients who were taking the same drug in a smaller dosage two or three times a day, had a significantly lower cost. By simply changing the dosage, they reduced the cost from $700 to just $9 a month. Download our case study to learn more on how St. Joseph Hospital cut costs around their pharma spend.

Administrative Costs

Costs related to planning, regulating and managing a health system account for eight percent of total spend in the U.S. compared to one to three percent in other countries. Health plans are always looking to improve efficiency, grow revenue and reduce overall costs, especially at the operating level but frequently run into roadblocks.

Presbyterian Health System (PHS), an integrated delivery system with eight hospitals in New Mexico, understands the challenges of balancing costs, utilization and quality all too well, as the organization struggled to oversee its entire business from one integrated view. However, after they partnered with MedeAnalytics, PHS was able to achieve measurable ROI in their financial, clinical and operational areas while reducing redundancies. For more on their approach to cut administrative costs, view here.

Despite the high cost of care facing the country, the U.S. is spearheading critical research into drugs, treatment and approaches that will change the state of care for so many patients. Learn more about how our analytics solutions can help you uncover insights to support your organization during these changing times.  You can view our solutions here or contact us here.

MedeAnalytics

MedeAnalytics is a leader in healthcare analytics, providing innovative solutions that enable measurable impact for healthcare payers and providers. With the most advanced data orchestration in healthcare, payers and providers count on us to deliver actionable insights that improve financial, operational, and clinical outcomes. To date, we’ve helped uncover millions of dollars in savings annually.

Leave a Comment





Get our take on industry trends

Healthcare’s return to “normal” after COVID-19: Is it possible?

June 9, 2020

As providers determine how to get patients to return to facilities for routine disease management and preventive screenings, opportunities are ripe for the application of analytics to triage at the right time to the right setting. Data related to COVID-19 will continue to flow rapidly, but there are possibly more questions than answers now about a return to “normal.”

Read on...

Avoid COVID-19 modeling pitfalls by eliminating bias, using good data

June 2, 2020

COVID-19 models are being used every day to predict the course and short- and long-term impacts of the pandemic. And we’ll be using these COVID-19 models for months to come.

Read on...

Population Health Amid the Coronavirus Outbreak

May 19, 2020

In speaking with many colleagues throughout the provider and payer healthcare community, I’ve found an overwhelming sense of helplessness to the outbreak’s onslaught. This is exacerbated by the constant evolution of reported underlying medical conditions that indicate a higher risk of hospitalization or mortality for a coronavirus patient.

Read on...

COVID-19 and the Financial Storm Ahead for Providers

May 14, 2020

Across the country, healthcare organizations are seeing 40%-80% declines in monthly charges with some of the most profitable services lines only seeing 20% of their normal monthly volumes during the pandemic.

Read on...